Duration of Thoracic Radiation Therapy With Concurrent Chemotherapy Is Important for the Outcome of Patients With Limited-Stage Small Cell Lung Cancer (L-SCLC)

被引：1
|
作者：
Komaki, R. U. [1 ]
Allen, P. [1 ]
Wei, X. [1 ]
Gomez, D. [1 ]
Kotamarti, K. R. [1 ]
Heymach, J. [1 ]
Welsh, J. [1 ]
O'Reilly, M. [1 ]
Lin, S. [1 ]
Cox, J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2013.06.1420
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S537 / S537
页数：1
相关论文
共 50 条
  • [21] Analysis of incidental radiation dose to uninvolved mediastinal/supraclavicular lymph nodes in patients with limited-stage small cell lung cancer (L-SCLC) treated without elective nodal irradiation (ENI)
    Ahmed, I. M.
    DeMarco, M.
    Stevens, C. W.
    Dilling, T. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S461 - S462
  • [22] Impact of radiation dose on concurrent chemoradiotherapy for limited-stage small-cell lung cancer
    Park, Junhee
    Kang, Min Kyu
    RADIATION ONCOLOGY JOURNAL, 2018, 36 (01): : 35 - 44
  • [23] Timing of Thoracic Radiation Therapy With Chemotherapy in Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns
    Farrell, Matthew J.
    Yahya, Jehan B.
    Degnin, Catherine
    Chen, Yiyi
    Holland, John M.
    Henderson, Mark A.
    Jaboin, Jerry J.
    Harkenrider, Matthew M.
    Thomas, Charles R., Jr.
    Mitin, Timur
    CLINICAL LUNG CANCER, 2018, 19 (06) : E815 - E821
  • [24] The Efficacy of Accelerated Radiation Therapy By Simultaneous Integrate Boosting Combined with Chemotherapy for Patients with Limited-Stage Small Cell Lung Cancer
    Su, M.
    You, J.
    Cui, J.
    Song, M.
    Jiang, L.
    Li, D.
    Yu, H.
    Yu, R.
    Shi, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E726 - E727
  • [25] Prophylactic cranial irradiation (PCI) in patients with prolonged survival in limited small cell lung cancer (L-SCLC)
    Tada, T
    Kawase, I
    Negoro, S
    Kurita, Y
    Tamura, T
    Saijo, N
    RADIOLOGY, 1998, 209P : 165 - 165
  • [26] Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer
    Colaco, Rovel J.
    Huh, Soon
    Nichols, Romaine C.
    Morris, Christopher G.
    D'Agostino, Harry
    Flampouri, Stella
    Li, Zuofeng
    Pham, Dat C.
    Bajwa, Abubakr A.
    Hoppe, Bradford S.
    ACTA ONCOLOGICA, 2013, 52 (03) : 506 - 513
  • [27] Timing of Thoracic Radiotherapy Is More Important Than Dose Escalation in Patients with Limited-Stage Small Cell Lung Cancer
    Hu, X.
    Xia, B.
    Bao, Y.
    Xu, Y.
    Wang, J.
    Ma, H.
    Jin, Y.
    Fang, M.
    Tang, H.
    Chen, M.
    Dong, B.
    Fu, X.
    Chen, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1802 - S1803
  • [28] Rationale for phase III trials of thoracic radiation therapy doses in limited-stage small-cell lung cancer
    Bogart, Jeffrey A.
    CLINICAL LUNG CANCER, 2008, 9 (04) : 202 - 205
  • [29] Split course versus continuous thoracic radiotherapy (TRT) for limited stage small cell lung cancer (L-SCLC): A randomized phase III trial
    Matthews, C
    Bogart, J
    White, D
    Case, LD
    Miller, A
    Blackstock, AW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S203 - S203
  • [30] Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis
    Zayed, Sondos
    Chen, Hanbo
    Ali, Emma
    Rodrigues, George B.
    Warner, Andrew
    Palma, David A.
    Louie, Alexander, V
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : 575 - 586
12345